RIPE PULMOBUTOL ETHRIFIN ETHRIFID P ISOTHAM CAMBUTOL-INH SAMBUTOL-INH RIFEDOT-4 AFRAZID-P AFRAZID AFRAZID AFRAZID INH AFRAZID INH RIMATOL FORTE P RIMATOL RIMATOL RIMATOL-P ACORET ACORET-P ETHAMBUTOL TIBEX-P TIBEX PIRE-R PIRE-P PIRE 3 PIRE+4 PIRE ETHAMBUTOL ETHAMBUTOL ETHAMBUTOL ETHAMBUTOL ETIBI INH NOVOBUTOL TBRID RIMTHREE FDC RIMCURE RIMSTAR BUTAL PANBUTOL PANBUTOL MYRAZID MYRAZID MYRAZID-P AMBUTOL MYRIN-P MYRIN MYRIN-P FORTE MYAMBUTOL MYAMBUTOL INH FORTE MYAMBUTOL-INH PHARBUTOL PHARBUTOL PHARBUTOL PLUS RIFIN-E RIFIN FORTE BUTAREX + INH ERI-P ERI-P FORTE U-BUTOL U-BUTOL+INH UBUTOL+3 UBUTOL+3 UBUTOL+2 UBUTOL+2 ATD+1 ATD+4 WILBUTOL-H WILBUTOL WILBUTOL RIFINZID-4 TUBERIN-P TUBERIN LISKOBUTOL LISKOBUTOL-INH TOLBUTAL TOFFCIN MEDIBUTOL MEDIBUTOL ETIBI AMANTE-PF RISEN RISEN P ROMIZID RAMBUZID ABBUTOL CYREX CYREX-P BUTAREX TUBERCURE-P TUBERCURE INH TUBERCURE SCHAZOBUTOL SCHAZOBUTOL-H RIFA 4 PLUS RIFA 4 RIFATOL MYCORID MYCORID P TUBERWIN-P FORTE TUBERWIN-P FORTE RANBUTOL INH FORTE

Dose: 15 to 25 mg/ kg
Single Dose: 20 (20)
Frequency: 24 hourly
Route: PO
Instructions: Initially for 60 Days.

Dose: SA
Single Dose:
Frequency:
Route:
Instructions:

Dose: 15 mg/kg
Single Dose: 15 (15)
Frequency: 24 hourly
Route: Oral
Instructions: Maintenance As Required

Ethambutol (HCl) also known as Ethambutol. . It is of Synthetic origin and belongs to Ethylaminobutan. It belongs to Antimycobacterial agent pharmacological group on the basis of mechanism of action. The Molecular Weight of Ethambutol (HCl) is 277.20. Its pKa is 6.3.

Ethambutol (HCl) is contraindicated in conditions like Optic neuritis.

The severe or irreversible adverse effects of Ethambutol (HCl), which give rise to further complications include Thrombocytopenia, Retrotubular neuritis, Pulmonary infiltrates.The symptomatic adverse reactions produced by Ethambutol (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Anorexia, Fever, Abdominal pain, Confusion, Hallucination, Malaise, Disorientation, Hyperuricemia, Joint pain, GI disturbance, Allergic rashes, Confusion, dizziness, Reduction invisual acuity, Green-red colour blindness.

Ethambutol (HCl) is primarily indicated in conditions like Acute leukemia, Non-tuberculous mycobacterial infection, and can also be given in adjunctive therapy as an alternative drug of choice in Tuberculosis.

Ethambutol (HCl) is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAluminium Hydroxide and OxideBromazepam These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

False Positive Screening Test for Phaeochromocytoma

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, Geriatrics, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store Below 40°C. Protect from Sunlight, Moisture and Heat.

Ethambutol should be used with caution in patients with history of gout, kidney disease or vision problems, such as cataracts. It should be used with caution during pregnancy or lactation.